 | • レポートコード：MRC2102QY2692 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のセフォタキシムナトリウムAPI市場について種類別（ChP、USP、EP）、用途別（シングルインジェクション、コンパウンドインジェクション）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・セフォタキシムナトリウムAPI市場の概要 ・世界の主要地域別セフォタキシムナトリウムAPI市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のセフォタキシムナトリウムAPI市場規模2015-2026：種類別（ChP、USP、EP） ・世界のセフォタキシムナトリウムAPI市場規模2015-2026：用途別（シングルインジェクション、コンパウンドインジェクション） ・セフォタキシムナトリウムAPIの米国市場規模2015-2020 ・セフォタキシムナトリウムAPIのヨーロッパ市場規模2015-2020 ・セフォタキシムナトリウムAPIの中国市場規模2015-2020 ・セフォタキシムナトリウムAPIの日本市場規模2015-2020 ・セフォタキシムナトリウムAPIの東南アジア市場規模2015-2020 ・セフォタキシムナトリウムAPIのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・セフォタキシムナトリウムAPIの製造コスト分析 ・販売チャネル、流通業者、顧客 ・セフォタキシムナトリウムAPIの市場動向・機会・課題 ・調査の結論 |
Cefotaxime sodium is the sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime sodium binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, cefotaxime sodium is more active against gram-negative bacteria and less active against gram-positive bacteria.
Market competition is intense. REYOUNG, Nectar Lifesciences, Medya Pharma, Sandoz, Kelun, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accountted for 57.98% market share in 2019.
Market Analysis and Insights: Global Cefotaxime Sodium API Market
The global Cefotaxime Sodium API market size is projected to reach US$ 97.2 million by 2026, from US$ 102.1 million in 2020, at a CAGR of -0.8% during 2021-2026.
Global Cefotaxime Sodium API Scope and Market Size
The global Cefotaxime Sodium API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cefotaxime Sodium API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Cefotaxime Sodium API market is segmented into
ChP
USP
EP
Chp refers to Chinese Pharmacopoeia. USP refers to the United States Pharmacopeia. EP refers to the European Pharmacopoeia. And the proportion of ChP in 2019 is about 77.92%.
Segment by Application, the Cefotaxime Sodium API market is segmented into
Single Injection
Compound Injection
Cefotaxime sodium API is widely for single injection and compound injection. The proportion of single injection in 2019 is about 76.02%.
The Cefotaxime Sodium API market is analysed and market size information is provided by regions (countries). Segment by Application, the Cefotaxime Sodium API market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cefotaxime Sodium API Market Share Analysis
Cefotaxime Sodium API market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cefotaxime Sodium API business, the date to enter into the Cefotaxime Sodium API market, Cefotaxime Sodium API product introduction, recent developments, etc.
The major vendors covered:
REYOUNG
Nectar Lifesciences
Medya Pharma
Sandoz
Kelun
NCPC
Aurobindo Pharma
United Laboratories
Orchid Pharma
CSPC
Kopran
Covalent
ACS Dobfar
Dawnrays
Sterile India
1 Cefotaxime Sodium API Market Overview
1.1 Cefotaxime Sodium API Product Scope
1.2 Cefotaxime Sodium API Segment by Type
1.2.1 Global Cefotaxime Sodium API Sales by Type (2020-2026)
1.2.2 ChP
1.2.3 USP
1.2.4 EP
1.3 Cefotaxime Sodium API Segment by Application
1.3.1 Global Cefotaxime Sodium API Sales Comparison by Application (2020-2026)
1.3.2 Single Injection
1.3.3 Compound Injection
1.4 Cefotaxime Sodium API Market Estimates and Forecasts (2015-2026)
1.4.1 Global Cefotaxime Sodium API Sales Growth Rate (2015-2026)
1.4.2 Global Cefotaxime Sodium API Revenue and Growth Rate (2015-2026)
1.4.3 Global Cefotaxime Sodium API Price Trends (2015-2026)
2 Cefotaxime Sodium API Estimate and Forecast by Region
2.1 Global Cefotaxime Sodium API Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Cefotaxime Sodium API Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Cefotaxime Sodium API Sales Market Share by Region (2015-2020)
2.2.2 Global Cefotaxime Sodium API Revenue Market Share by Region (2015-2020)
2.3 Global Cefotaxime Sodium API Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Cefotaxime Sodium API Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Cefotaxime Sodium API Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cefotaxime Sodium API Estimates and Projections (2015-2026)
2.4.2 Europe Cefotaxime Sodium API Estimates and Projections (2015-2026)
2.4.3 China Cefotaxime Sodium API Estimates and Projections (2015-2026)
2.4.4 Japan Cefotaxime Sodium API Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Cefotaxime Sodium API Estimates and Projections (2015-2026)
2.4.6 India Cefotaxime Sodium API Estimates and Projections (2015-2026)
3 Global Cefotaxime Sodium API Competition Landscape by Players
3.1 Global Top Cefotaxime Sodium API Players by Sales (2015-2020)
3.2 Global Top Cefotaxime Sodium API Players by Revenue (2015-2020)
3.3 Global Cefotaxime Sodium API Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cefotaxime Sodium API as of 2019)
3.4 Global Cefotaxime Sodium API Average Price by Company (2015-2020)
3.5 Manufacturers Cefotaxime Sodium API Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Cefotaxime Sodium API Players (Opinion Leaders)
4 Global Cefotaxime Sodium API Market Size by Type
4.1 Global Cefotaxime Sodium API Historic Market Review by Type (2015-2020)
4.1.1 Global Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
4.1.2 Global Cefotaxime Sodium API Revenue Market Share by Type (2015-2020)
4.1.3 Global Cefotaxime Sodium API Price by Type (2015-2020)
4.2 Global Cefotaxime Sodium API Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Cefotaxime Sodium API Sales Forecast by Type (2021-2026)
4.2.2 Global Cefotaxime Sodium API Revenue Forecast by Type (2021-2026)
4.2.3 Global Cefotaxime Sodium API Price Forecast by Type (2021-2026)
5 Global Cefotaxime Sodium API Market Size by Application
5.1 Global Cefotaxime Sodium API Historic Market Review by Application (2015-2020)
5.1.1 Global Cefotaxime Sodium API Sales Market Share by Application (2015-2020)
5.1.2 Global Cefotaxime Sodium API Revenue Market Share by Application (2015-2020)
5.1.3 Global Cefotaxime Sodium API Price by Application (2015-2020)
5.2 Global Cefotaxime Sodium API Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Cefotaxime Sodium API Sales Forecast by Application (2021-2026)
5.2.2 Global Cefotaxime Sodium API Revenue Forecast by Application (2021-2026)
5.2.3 Global Cefotaxime Sodium API Price Forecast by Application (2021-2026)
6 United States Cefotaxime Sodium API Market Facts & Figures
6.1 United States Cefotaxime Sodium API Sales Market Share by Company (2015-2020)
6.2 United States Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
6.3 United States Cefotaxime Sodium API Sales Market Share by Application (2015-2020)
7 Europe Cefotaxime Sodium API Market Facts & Figures
7.1 Europe Cefotaxime Sodium API Sales Market Share by Company (2015-2020)
7.2 Europe Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
7.3 Europe Cefotaxime Sodium API Sales Market Share by Application (2015-2020)
8 China Cefotaxime Sodium API Market Facts & Figures
8.1 China Cefotaxime Sodium API Sales Market Share by Company (2015-2020)
8.2 China Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
8.3 China Cefotaxime Sodium API Sales Market Share by Application (2015-2020)
9 Japan Cefotaxime Sodium API Market Facts & Figures
9.1 Japan Cefotaxime Sodium API Sales Market Share by Company (3015-3030)
9.2 Japan Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
9.3 Japan Cefotaxime Sodium API Sales Market Share by Application (2015-2020)
10 Southeast Asia Cefotaxime Sodium API Market Facts & Figures
10.1 Southeast Asia Cefotaxime Sodium API Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Cefotaxime Sodium API Sales Market Share by Application (2015-2020)
11 India Cefotaxime Sodium API Market Facts & Figures
11.1 India Cefotaxime Sodium API Sales Market Share by Company (2015-2020)
11.2 India Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
11.3 India Cefotaxime Sodium API Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Cefotaxime Sodium API Business
12.1 REYOUNG
12.1.1 REYOUNG Corporation Information
12.1.2 REYOUNG Business Overview
12.1.3 REYOUNG Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.1.4 REYOUNG Cefotaxime Sodium API Products Offered
12.1.5 REYOUNG Recent Development
12.2 Nectar Lifesciences
12.2.1 Nectar Lifesciences Corporation Information
12.2.2 Nectar Lifesciences Business Overview
12.2.3 Nectar Lifesciences Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Nectar Lifesciences Cefotaxime Sodium API Products Offered
12.2.5 Nectar Lifesciences Recent Development
12.3 Medya Pharma
12.3.1 Medya Pharma Corporation Information
12.3.2 Medya Pharma Business Overview
12.3.3 Medya Pharma Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Medya Pharma Cefotaxime Sodium API Products Offered
12.3.5 Medya Pharma Recent Development
12.4 Sandoz
12.4.1 Sandoz Corporation Information
12.4.2 Sandoz Business Overview
12.4.3 Sandoz Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sandoz Cefotaxime Sodium API Products Offered
12.4.5 Sandoz Recent Development
12.5 Kelun
12.5.1 Kelun Corporation Information
12.5.2 Kelun Business Overview
12.5.3 Kelun Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Kelun Cefotaxime Sodium API Products Offered
12.5.5 Kelun Recent Development
12.6 NCPC
12.6.1 NCPC Corporation Information
12.6.2 NCPC Business Overview
12.6.3 NCPC Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.6.4 NCPC Cefotaxime Sodium API Products Offered
12.6.5 NCPC Recent Development
12.7 Aurobindo Pharma
12.7.1 Aurobindo Pharma Corporation Information
12.7.2 Aurobindo Pharma Business Overview
12.7.3 Aurobindo Pharma Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Aurobindo Pharma Cefotaxime Sodium API Products Offered
12.7.5 Aurobindo Pharma Recent Development
12.8 United Laboratories
12.8.1 United Laboratories Corporation Information
12.8.2 United Laboratories Business Overview
12.8.3 United Laboratories Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.8.4 United Laboratories Cefotaxime Sodium API Products Offered
12.8.5 United Laboratories Recent Development
12.9 Orchid Pharma
12.9.1 Orchid Pharma Corporation Information
12.9.2 Orchid Pharma Business Overview
12.9.3 Orchid Pharma Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Orchid Pharma Cefotaxime Sodium API Products Offered
12.9.5 Orchid Pharma Recent Development
12.10 CSPC
12.10.1 CSPC Corporation Information
12.10.2 CSPC Business Overview
12.10.3 CSPC Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CSPC Cefotaxime Sodium API Products Offered
12.10.5 CSPC Recent Development
12.11 Kopran
12.11.1 Kopran Corporation Information
12.11.2 Kopran Business Overview
12.11.3 Kopran Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Kopran Cefotaxime Sodium API Products Offered
12.11.5 Kopran Recent Development
12.12 Covalent
12.12.1 Covalent Corporation Information
12.12.2 Covalent Business Overview
12.12.3 Covalent Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Covalent Cefotaxime Sodium API Products Offered
12.12.5 Covalent Recent Development
12.13 ACS Dobfar
12.13.1 ACS Dobfar Corporation Information
12.13.2 ACS Dobfar Business Overview
12.13.3 ACS Dobfar Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.13.4 ACS Dobfar Cefotaxime Sodium API Products Offered
12.13.5 ACS Dobfar Recent Development
12.14 Dawnrays
12.14.1 Dawnrays Corporation Information
12.14.2 Dawnrays Business Overview
12.14.3 Dawnrays Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Dawnrays Cefotaxime Sodium API Products Offered
12.14.5 Dawnrays Recent Development
12.15 Sterile India
12.15.1 Sterile India Corporation Information
12.15.2 Sterile India Business Overview
12.15.3 Sterile India Cefotaxime Sodium API Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Sterile India Cefotaxime Sodium API Products Offered
12.15.5 Sterile India Recent Development
13 Cefotaxime Sodium API Manufacturing Cost Analysis
13.1 Cefotaxime Sodium API Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cefotaxime Sodium API
13.4 Cefotaxime Sodium API Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cefotaxime Sodium API Distributors List
14.3 Cefotaxime Sodium API Customers
15 Market Dynamics
15.1 Cefotaxime Sodium API Market Trends
15.2 Cefotaxime Sodium API Opportunities and Drivers
15.3 Cefotaxime Sodium API Market Challenges
15.4 Cefotaxime Sodium API Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Cefotaxime Sodium API Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Cefotaxime Sodium API Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Cefotaxime Sodium API Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Cefotaxime Sodium API Sales (MT) by Region (2015-2020)
Table 5. Global Cefotaxime Sodium API Sales Market Share by Region (2015-2020)
Table 6. Global Cefotaxime Sodium API Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Cefotaxime Sodium API Revenue Share by Region (2015-2020)
Table 8. Global Cefotaxime Sodium API Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Cefotaxime Sodium API Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Cefotaxime Sodium API Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Cefotaxime Sodium API Revenue Share Forecast by Region (2021-2026)
Table 12. Global Cefotaxime Sodium API (MT) of Key Companies (2015-2020)
Table 13. Global Cefotaxime Sodium API Sales Share by Company (2015-2020)
Table 14. Global Cefotaxime Sodium API Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Cefotaxime Sodium API Revenue Share by Company (2015-2020)
Table 16. Global Cefotaxime Sodium API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cefotaxime Sodium API as of 2019)
Table 17. Global Cefotaxime Sodium API Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Cefotaxime Sodium API Manufacturing Sites and Area Served
Table 19. Manufacturers Cefotaxime Sodium API Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Cefotaxime Sodium API Players
Table 22. Global Cefotaxime Sodium API Sales (MT) by Type (2015-2020)
Table 23. Global Cefotaxime Sodium API Sales Share by Type (2015-2020)
Table 24. Global Cefotaxime Sodium API Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Cefotaxime Sodium API Price (MT) by Type (2015-2020)
Table 26. Global Cefotaxime Sodium API Sales Share by Type (2021-2026)
Table 27. Global Cefotaxime Sodium API Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Cefotaxime Sodium API Revenue Share by Type (2021-2026)
Table 29. Global Cefotaxime Sodium API Price (MT) by Type (2021-2026)
Table 30. Global Cefotaxime Sodium API Sales (MT) by Application (2015-2020)
Table 31. Global Cefotaxime Sodium API Sales Share by Application (2015-2020)
Table 32. Global Cefotaxime Sodium API Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Cefotaxime Sodium API Price (MT) by Application (2015-2020)
Table 34. Global Cefotaxime Sodium API Sales (MT) by Application (2021-2026)
Table 35. Global Cefotaxime Sodium API Sales Share by Application (2021-2026)
Table 36. Global Cefotaxime Sodium API Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Cefotaxime Sodium API Revenue Share by Application (2021-2026)
Table 38. Global Cefotaxime Sodium API Price (MT) by Application (2021-2026)
Table 39. United States Cefotaxime Sodium API Sales (MT) by Company (2015-2020)
Table 40. United States Cefotaxime Sodium API Sales Market Share by Company (2015-2020)
Table 41. United States Cefotaxime Sodium API Sales (MT) by Type (2015-2020)
Table 42. United States Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
Table 43. United States Cefotaxime Sodium API Sales (MT) by Application (2015-2020)
Table 44. United States Cefotaxime Sodium API Sales Market Share by Application (2015-2020)
Table 45. Europe Cefotaxime Sodium API Sales (MT) by Company (2015-2020)
Table 46. Europe Cefotaxime Sodium API Sales Market Share by Company (2015-2020)
Table 47. Europe Cefotaxime Sodium API Sales (MT) by Type (2015-2020)
Table 48. Europe Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
Table 49. Europe Cefotaxime Sodium API Sales (MT) by Application (2015-2020)
Table 50. Europe Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
Table 51. China Cefotaxime Sodium API Sales (MT) by Company (2015-2020)
Table 52. China Cefotaxime Sodium API Sales Market Share by Company (2015-2020)
Table 53. China Cefotaxime Sodium API Sales (MT) by Type (2015-2020)
Table 54. China Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
Table 55. China Cefotaxime Sodium API Sales (MT) by Application (2015-2020)
Table 56. China Cefotaxime Sodium API Sales Market Share by Application (2015-2020)
Table 57. Japan Cefotaxime Sodium API Sales (MT) by Company (2015-2020)
Table 58. Japan Cefotaxime Sodium API Sales Market Share by Company (2015-2020)
Table 59. Japan Cefotaxime Sodium API Sales (MT) by Type (2015-2020)
Table 60. Japan Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
Table 61. Japan Cefotaxime Sodium API Sales (MT) by Application (2015-2020)
Table 62. Japan Cefotaxime Sodium API Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Cefotaxime Sodium API Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Cefotaxime Sodium API Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Cefotaxime Sodium API Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Cefotaxime Sodium API Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Cefotaxime Sodium API Sales Market Share by Application (2015-2020)
Table 69. India Cefotaxime Sodium API Sales (MT) by Company (2015-2020)
Table 70. India Cefotaxime Sodium API Sales Market Share by Company (2015-2020)
Table 71. India Cefotaxime Sodium API Sales (MT) by Type (2015-2020)
Table 72. India Cefotaxime Sodium API Sales Market Share by Type (2015-2020)
Table 73. India Cefotaxime Sodium API Sales (MT) by Application (2015-2020)
Table 74. India Cefotaxime Sodium API Sales Market Share by Application (2015-2020)
Table 75. REYOUNG Corporation Information
Table 76. REYOUNG Description and Business Overview
Table 77. REYOUNG Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. REYOUNG Cefotaxime Sodium API Product
Table 79. REYOUNG Recent Development
Table 80. Nectar Lifesciences Corporation Information
Table 81. Nectar Lifesciences Description and Business Overview
Table 82. Nectar Lifesciences Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Nectar Lifesciences Cefotaxime Sodium API Product
Table 84. Nectar Lifesciences Recent Development
Table 85. Medya Pharma Corporation Information
Table 86. Medya Pharma Description and Business Overview
Table 87. Medya Pharma Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Medya Pharma Cefotaxime Sodium API Product
Table 89. Medya Pharma Recent Development
Table 90. Sandoz Corporation Information
Table 91. Sandoz Description and Business Overview
Table 92. Sandoz Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Sandoz Cefotaxime Sodium API Product
Table 94. Sandoz Recent Development
Table 95. Kelun Corporation Information
Table 96. Kelun Description and Business Overview
Table 97. Kelun Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Kelun Cefotaxime Sodium API Product
Table 99. Kelun Recent Development
Table 100. NCPC Corporation Information
Table 101. NCPC Description and Business Overview
Table 102. NCPC Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. NCPC Cefotaxime Sodium API Product
Table 104. NCPC Recent Development
Table 105. Aurobindo Pharma Corporation Information
Table 106. Aurobindo Pharma Description and Business Overview
Table 107. Aurobindo Pharma Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Aurobindo Pharma Cefotaxime Sodium API Product
Table 109. Aurobindo Pharma Recent Development
Table 110. United Laboratories Corporation Information
Table 111. United Laboratories Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. United Laboratories Description and Business Overview
Table 113. United Laboratories Cefotaxime Sodium API Product
Table 114. United Laboratories Recent Development
Table 115. Orchid Pharma Corporation Information
Table 116. Orchid Pharma Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Orchid Pharma Description and Business Overview
Table 118. Orchid Pharma Cefotaxime Sodium API Product
Table 119. Orchid Pharma Recent Development
Table 120. CSPC Corporation Information
Table 121. CSPC Description and Business Overview
Table 122. CSPC Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. CSPC Cefotaxime Sodium API Product
Table 124. CSPC Recent Development
Table 125. Kopran Corporation Information
Table 126. Kopran Description and Business Overview
Table 127. Kopran Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Kopran Cefotaxime Sodium API Product
Table 129. Kopran Recent Development
Table 130. Covalent Corporation Information
Table 131. Covalent Description and Business Overview
Table 132. Covalent Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Covalent Cefotaxime Sodium API Product
Table 134. Covalent Recent Development
Table 135. ACS Dobfar Corporation Information
Table 136. ACS Dobfar Description and Business Overview
Table 137. ACS Dobfar Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. ACS Dobfar Cefotaxime Sodium API Product
Table 139. ACS Dobfar Recent Development
Table 140. Dawnrays Corporation Information
Table 141. Dawnrays Description and Business Overview
Table 142. Dawnrays Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Dawnrays Cefotaxime Sodium API Product
Table 144. Dawnrays Recent Development
Table 145. Sterile India Corporation Information
Table 146. Sterile India Description and Business Overview
Table 147. Sterile India Cefotaxime Sodium API Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Sterile India Cefotaxime Sodium API Product
Table 149. Sterile India Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Cefotaxime Sodium API Distributors List
Table 153. Cefotaxime Sodium API Customers List
Table 154. Cefotaxime Sodium API Market Key Trends
Table 155. Cefotaxime Sodium API Key Opportunities and Drivers
Table 156. Cefotaxime Sodium API Market Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Cefotaxime Sodium API Product Picture
Figure 2. Global Cefotaxime Sodium API Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cefotaxime Sodium API Market Share by Application in 2020 & 2026
Figure 6. Single Injection Examples
Figure 7. Compound Injection Examples
Figure 8. Global Cefotaxime Sodium API Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Cefotaxime Sodium API Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Cefotaxime Sodium API Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Cefotaxime Sodium API Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Cefotaxime Sodium API Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Cefotaxime Sodium API Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Cefotaxime Sodium API Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Cefotaxime Sodium API Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Cefotaxime Sodium API Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Cefotaxime Sodium API Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Cefotaxime Sodium API Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Cefotaxime Sodium API Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Cefotaxime Sodium API Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Cefotaxime Sodium API Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Cefotaxime Sodium API Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Cefotaxime Sodium API Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Cefotaxime Sodium API Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Cefotaxime Sodium API Players Market Share by Revenue in Cefotaxime Sodium API 2015 & 2019
Figure 26. Cefotaxime Sodium API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Cefotaxime Sodium API Revenue Share by Type (2015-2020)
Figure 28. Global Cefotaxime Sodium API Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Cefotaxime Sodium API Revenue Share by Application (2015-2020)
Figure 30. Global Cefotaxime Sodium API Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Cefotaxime Sodium API Sales Market Share by Type in 2019
Figure 32. United States Cefotaxime Sodium API Sales Market Share by Type in 2019
Figure 33. Europe Cefotaxime Sodium API Sales Market Share by Company in 2019
Figure 34. Europe Cefotaxime Sodium API Sales Market Share by Type in 2019
Figure 35. Europe Cefotaxime Sodium API Sales Market Share by Application in 2019
Figure 36. China Cefotaxime Sodium API Sales Market Share by Company in 2019
Figure 37. China Cefotaxime Sodium API Sales Market Share by Type in 2019
Figure 38. China Cefotaxime Sodium API Sales Market Share by Application in 2019
Figure 39. Japan Cefotaxime Sodium API Sales Market Share by Company in 2019
Figure 40. Japan Cefotaxime Sodium API Sales Market Share by Type in 2019
Figure 41. Japan Cefotaxime Sodium API Sales Market Share by Application in 2019
Figure 42. Southeast Asia Cefotaxime Sodium API Sales Market Share by Company in 2019
Figure 43. Southeast Asia Cefotaxime Sodium API Sales Market Share by Type in 2019
Figure 44. Southeast Asia Cefotaxime Sodium API Sales Market Share by Application in 2019
Figure 45. India Cefotaxime Sodium API Sales Market Share by Company in 2019
Figure 46. India Cefotaxime Sodium API Sales Market Share by Type in 2019
Figure 47. India Cefotaxime Sodium API Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Cefotaxime Sodium API
Figure 50. Manufacturing Process Analysis of Cefotaxime Sodium API
Figure 51. Cefotaxime Sodium API Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
スルファジアジンナトリウム注射の世界市場レポート2020 Sulfadiazine sodium injection indications for this product is mainly used for the treatment of sensitive neisseria meningitidis caused by meningitis patients. Market Analysis and Insights: Global Sulfadiazine Sodium Injection Market The global Sulfadiazine Sodium Injection market size is projected t…- 塩化ナトリウム注射液の世界市場レポート2020 Sodium Chloride Injection, which is mostly the 0.9% sodium chloride water, also called as normal saline. It is a colorless, clear liquid. And it is sterile and no pyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intrave…
- ドキュセートナトリウムの世界市場レポート2020 Docusate sodium is a versatile and highly effective and efficient pharmaceutical grade surfactant. Docusate sodium is often used as an exicipient in pharmaceutical production processes where it acts as a solubilizing agent for poorly soluble API's as well as a dispersing and emulsifying agent. It is…
- アジ化ナトリウムの世界市場レポート2020 Market Analysis and Insights: Global Sodium Azide Market The global Sodium Azide market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Sodium Azide Scope and Market Size The global Sodium Azide market is segmented by company,…
- アジピン酸ナトリウムの世界市場レポート2020 Market Analysis and Insights: Global Sodium Adipate Market The global Sodium Adipate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Sodium Adipate Scope and Market Size The global Sodium Adipate market is segmented by …